Skip to content

Trevi Therapeutics, Inc. TRVI Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale at other companies

Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$316.86M+3,076%
Lincoln National logo
Lincoln NationalLNC
$2.6B-3.5%
The Bancorp logo
The BancorpTBBK
$25.58M-46.6%
First BanCorp logo
First BanCorpFBP
$690.52M+98.8%
Columbia Financial, Inc. logo
Columbia Financial, Inc.CLBK
$57.11M+91.4%
Repligen logo
RepligenRGEN
$66M

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s proceeds from maturities, prepayments and calls of debt securities, available-for-sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s proceeds from maturities, prepayments and calls of debt securities, available-for-sale?
Trevi Therapeutics, Inc. (TRVI) reported proceeds from maturities, prepayments and calls of debt securities, available-for-sale of $25.55M in Q1 2026.
How has Trevi Therapeutics, Inc.'s proceeds from maturities, prepayments and calls of debt securities, available-for-sale changed year-over-year?
Trevi Therapeutics, Inc.'s proceeds from maturities, prepayments and calls of debt securities, available-for-sale increased by 45.2% year-over-year, from $17.6M to $25.55M.
What is the long-term trend for Trevi Therapeutics, Inc.'s proceeds from maturities, prepayments and calls of debt securities, available-for-sale?
Over 2 years (2023 to 2025), Trevi Therapeutics, Inc.'s proceeds from maturities, prepayments and calls of debt securities, available-for-sale has grown at a 5.0% compound annual growth rate (CAGR), from $69.5M to $76.57M.
What does proceeds from maturities, prepayments and calls of debt securities, available-for-sale mean?
Indicates the cash inflows received from the maturity, redemption, or prepayment of debt securities held in the company's investment portfolio. This metric highlights the liquidity generated from the company's treasury management and investment activities.